Baba,

I looked into IMUC in June, after reading a seeking alpha article on MNKD. I even ran it by a few friends, but in the end I did not understand the science well enough to invest in it. I would love to hear what others with a medical background think about it.

It looks interesting, with one drug in P2 expecting completion at the end of the year. The drug attacks cancer stem cells.

Here is the link to the article.

http://seekingalpha.com/article/1502122-for-love-and-money-3-growth-stocks-from-casey-s-alex-daley?source=yahoo

The Corporate Fact Sheet, which can be found on their web-site, also has a good summary.

http://files.shareholder.com/downloads/AMDA-1HS8HT/2601232415x0x629387/5B1C2012-52FF-4B88-9127-E287829C9AB0/Corporate_Fact_Sheet.pdf

Bob